Insiders · Profile

MOATAZEDI DAVID

See Remarks at Evolus · Director at BIOMERICA. Filing since 25 Jan 2021. CIK 0001700836

Company
Date
Role
Action
Shares
Amount
Of holding
2 Sep 2026
See Remarks
Sold at will
105,108
$950.02K
17.4%
26 Aug 2026
Director
Bought
10,000
$16.00K
32.7%
20 Mar 2026
See Remarks
Sold on a plan
13,669
$64.93K
2.2%
17 Mar 2026
See Remarks
Sold on a plan
116,720
$570.56K
15.9%
22 Dec 2025
See Remarks
Sold on a plan
10,539
$75.36K
2.9%
16 Jun 2025
See Remarks
Sold at will
16,582
$164.05K
4.3%
13 Jun 2025
See Remarks
Sold at will
111,323
$1.12M
22.6%
12 May 2025
See Remarks
Sold on a plan
15,787
$155.76K
3.1%
27 Mar 2025
See Remarks
Sold on a plan
6,251
$77.51K
1.2%
18 Mar 2025
See Remarks
Sold on a plan
103,376
$1.37M
16.7%
23 Dec 2024
See Remarks
Sold on a plan
10,502
$113.97K
2.0%
6 Jun 2024
See Remarks
Sold at will
175,940
$2.21M
24.8%
5 Jun 2024
See Remarks
Sold at will
155,278
$2.01M
22.5%
4 Jun 2024
See Remarks
Sold at will
140,214
$1.78M
20.8%
10 May 2024
See Remarks
Sold at will
16,051
$204.13K
2.3%
27 Mar 2024
See Remarks
Sold at will
6,236
$86.43K
0.9%
19 Mar 2024
See Remarks
Sold at will
96,566
$1.34M
12.2%
22 Feb 2024
See Remarks
Sold on a plan
7,706
$100.80K
1.0%
8 Dec 2023
See Remarks
Sold at will
31,300
$304.51K
4.9%
6 Dec 2023
See Remarks
Sold at will
51,348
$517.89K
7.5%
16 Aug 2023
See Remarks
Sold on a plan
14,778
$151.77K
2.1%
27 Mar 2023
See Remarks
Sold on a plan
6,110
$51.75K
1.0%
14 Mar 2023
See Remarks
Sold, plan not stated
64,211
$543.80K
9.4%
16 May 2022
See Remarks
Sold, plan not stated
55,321
$754.31K
10.1%
28 Mar 2022
See Remarks
Sold, plan not stated
6,104
$70.93K
1.1%
8 Mar 2022
See Remarks
Sold, plan not stated
37,972
$369.29K
6.4%
16 Aug 2021
See Remarks
Sold, plan not stated
47,737
$541.74K
11.2%
13 Aug 2021
See Remarks
Sold, plan not stated
22,708
$242.07K
5.1%
10 Aug 2021
See Remarks
Bought
41,763
$466.84K
8.5%
25 Jan 2021
See Remarks
Sold, plan not stated
8,310
$61.99K
4.6%
30 decisions on file.